Eli Lilly and Company (LLY) short interest & options flow
NYSEEli Lilly and Company delivered its Q3 results on October 29, closing the day at $1,373.70, a 6.6% single-session gain that extended the stock's one-month rise to 16%. Within hours of the print, four analyst firms raised their price targets, with the highest new target sitting at $1,612. The post-earnings response from the Street was immediate. Truist…
LLY cost to
Full pulse commentary is for ORTEX subscribers. The live data picture for LLY below stays open — short interest, options flow, signals, and historical context.
Sign up free to read pulse →Short interest % of float, cost to borrow, utilization, and put/call ratio for LLY are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
- Market cap
- $1.26T
- Next earnings
- 5 Feb 2027
Key data as of 3 Nov 2026
Latest signals on LLY
- Cost to Borrow
LLY cost to
LLY Stock Report — available now on ORTEX
A new long-form analysis for LLY this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumLLY news and analysis
RSSNo long-form analysis yet for LLY. Pulse alerts and the live data picture are available on ORTEX.
Open LLY on ORTEX →Want the live picture for LLY?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LLY — free to start on ORTEX.
Sign up for free →Open LLY on ORTEX